This week, a familiar name tops the annual list of best ophthalmology hospitals, a small study suggests vitamin B3 could improve visual function among glaucomatous eyes and Santen gains rights to a blepharoptosis drug outside of the United States. Source: AAO
This prospective, longitudinal study assessed whether anterior chamber inflammation affects the corneal endothelium in children. Source: AAO
The NIH announced the appointment of Michael Chiang, MD, as director of the National Eye Institute (NEI). Source: AAO
This week, a study suggests some low-carb diets may help combat glaucoma, an innovative reinnervation surgery for facial paralysis and CorNeat’s novel keratoprosthesis is cleared for clinical trials in Israel. Source: AAO
This study is the first to report the clinical features of glaucoma associated with a TANK binding kinase (TBK1) gene duplication. Source: AAO
This article provides consensus guidelines to steer the treatment of patients with noninfectious uveitis during the COVID-19 pandemic. Source: AAO
This study characterized firework-related injuries in the United States to determine specific actionable associations that could guide public policies and reduce the extent of ocular injuries. Source: AAO
This study investigated the association of parental myopia with refractive error and ocular biometry in multiethnic children aged 6 to 72 months. Source: AAO
This week, an experimental eye drop for cataract snags an NEI grant, scientists develop a liquid-hydrogel alternative to corneal transplants and snapping shrimp prove they have the fastest eyes in the water. Source: AAO
This review highlights the current literature and best practice guidelines on the use of immunosuppression in the time of the COVID-19 pandemic. Source: AAO